What’s up everyone so in today’s video, I share with you three top penny stocks, which
Cathie Wood of Ark Invest has been loading up on.
For those who are not familiar with Cathie Woods investing style, they fundamentally
invest in disruptive innovative stocks for the long term and typically go for mid to
large cap stocks with higher liquidity.
So to see them loading up on these penny stocks at this stage, it speaks of their conviction
and strong belief on what these stocks have to offer.
So the key here is that these penny stocks are potential long term plays and so only
get in, if you fully understand their risks, you like their story or business model and
if the price is right for you, as this is not financial advise...
So make sure you don’t miss out on these big bangers by liking the video and turn on
the notification bell to get these hot penny stocks instantly.
And also if you want two free stocks worth over $1800 from Webull and also where you
can buy fractional shares, please hit the link in the top comment or description below.
I would really appreciate it.
Thank you so much.
So let’s get straight into it, with our number 3 penny stock here, which is Purple
Biotech ADR (PPBT).
It has a share price sitting at $5.59 and market cap of $98m.
This penny stock is up 14.5% over the last month and YTD it is up 37.6%.
And going by its recent peaks and troughs it seems a very sensitive stock to news and
one which could provide decent swing trade opportunities.
It actually seems to be running up right now on the back of latest news.
So one to wait for it to cool down as we aim buy low and sell high.
Purple Biotech is Nasdaq Listed with an average of 259k shares traded over a 30day period
and over 17.6m shares outstanding.
So very tightly held shares.
Purple Biotech Ltd.
(NASDAQ/TASE: PPBT) is a clinical-stage company focused on advancing first-in-class therapies
to overcome tumor immune evasion and drug resistance to create effective, durable treatments
for cancer patients.
They have two programmes in their pipeline: first CM24, which is a first-in-class clinical
stage drug targeting a novel immune checkpoint inhibitor with significant potential to treat
multiple cancers.
In a Phase 1 dose-escalation study, CM24 demonstrated a good safety profile and promising efficacy
signals.
And they are developing CM24 in collaboration with Bristol Myers-Squibb via a Phase 1/2
trials.
Their topline data results are expected in the second half of 2021.
Their second programme is NT219, which is a first-in-class, novel small molecule targeting
both important oncogenic drivers and major drug resistance pathways in many hard-to-treat
cancers.
Ark Invest is presently holding over 737k shares worth over $4.1m in their Israel Innovation
Tech ETF.
They started loading up on the stock on the 13th of July when it was still trading at
$4.4 and have gradually built their position in the stock to over 700k shares.
So still very early days on the stock but exciting times ahead as more results get released
on their two programmes.
Next up to our number 2 penny stock here, which is Entera Bio Ltd
(ENTX).
It has a share price sitting at $5 per share and market cap of $121m.
This penny stock is down 16.3% over the last month but year to date it is up 303% having
had some decent jumps recently and its now cooling down and pulling back slowly but I
don’t think it has bottomed out yet, so certainly one to watch and strike in when
the price is right for you.
Entera is Nasdaq Listed with an average of 6.4m shares traded over a 30day period and
over 23.7m shares outstanding.
Entera is a leader in the development of orally delivered large molecule therapeutics, for
use in areas with significant unmet medical need where adoption of injectable therapies
is limited due to cost, convenience and compliance challenges for patients.
Entera also licenses its technology to biopharmaceutical companies for use with their proprietary compounds
and, to date, has established a collaboration with Amgen Inc.
Entera recently announced Excellent Topline Phase 2 BMD Data for EB613, as the Study Met
Its Primary and Key Secondary Endpoints.
Subjects receiving the 2.5 mg dose of EB613 showed significant dose-related increases
in bone mineral density BMD at the lumbar spine, total hip, and femoral neck at 6 months.
EB613 is an oral formulation positioned to be the first oral bone building (anabolic)
product to treat osteoporosis patients..
An End of Phase 2 meeting with the FDA to review the EB613 development program is anticipated
in the coming months.
Ark Invest is presently holding over 531k shares worth over $2.7m in their Israel Innovation
Tech ETF.
The started loading up on the stock on the 15th of July when it was still trading at
$5.2 and have gradually built their position in the stock to over 500k.
Entera has 3 analysts covering the stock with a strong buy rating.
The analysts mid price target of $12 per share gives it an upside opportunity of over 140%
over the next 12 months.
So really exciting times ahead.
Next to our number 1 penny stock here, which is Conformis Inc (CFMS).
It has a share price sitting at $1.46 and market cap of $267.3m.
This penny stock is up 26.9% on the month and up 121% YTD.
It has been showing strong momentum over the last few trading days on the back of recent
news that could see it take continue to fly.
Conformis is Nasdaq Listed with an average of 3.6m shares traded over a 30day period
and over 182.4m shares outstanding.
Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant®
technology platform to develop, manufacture and sell joint replacement implants that are
individually sized and shaped, or customized, to fit each patient's unique anatomy.
Conformis offers a broad line of customized knee and hip implants and customized pre-sterilized,
single-use instruments delivered in a single package to the hospital.
Conformis Reported First Quarter 2021 Financial Results, which saw Total revenue of $13.8
million, decrease of 16% year-on-year.
The decrease in revenue was driven primarily by lower volume due to the impact of the COVID-19
pandemic on elective procedures.
Their Gross margin of 45%, was an increase of 80 basis points year-on-year.
They announced the execution of an agreement to enter the Asia-Pacific market through an
exclusive distribution relationship with XR Medical Group (Hong Kong) Limited . And Under
the distribution agreement, XR Medical will have exclusive rights for the sale, marketing,
and distribution of Conformis’ patient-specific iTotal® total knee replacement systems.
The global market for knee joint reconstruction is projected at more than $9 billion.
Of this total, the knee joint reconstruction market in the Asia-Pacific region is currently
estimated to exceed $1.7 billion.
Fortune Business Insights predicts a high growth rate for knee replacements in the region
due to the combination of the increased prevalence of knee disorders, booming medical tourism,
increased disposable incomes, and improved healthcare infrastructure, which is all really
exciting prospects for the outlook of this stock.
So here’s the penny stock Ark Invest has been loading up on the most.
They are presently holding over 12.8m shares worth over $18.6m in their 3D Printing ETF.
Ark Invest started loading up on the penny stock on the 14th of July when it was still
trading at $1.10 and have gradually cost averaged in building their position in the stock to
over 12.8m shares.
Entera has 2 analysts covering the stock with a buy rating.
And The analysts mid price target of $2.5 per share gives it an upside of over 66%;
and the upper price target of $3 gives an upside of 100% over the next 12 months.
So reallu exciting times ahead.
So a very interesting and mindblowing prospects ahead for these penny stocks but only consider
getting in if the price is right for you and if you fully understand the risks.
This video is not financial advice, a buy or a sell recommendation, but is meant to
bring some new and exciting penny stocks to your attention for you to do your own research..
As always I would love to hear from you, so please let me know your thoughts on these
top penny stocks in the comments section below and what other penny stocks are catching your
eyes lately.
And If you are new to my channel please ensure to subscribe and hit the bell so you are notified
when I upload new videos.
If you would like to see more videos like this, please check out this video right here
or this playlist right here to watch equally insightful content from the channel.
Thank you so much for being here and I look forward to have you in my next video.
Thank you